Willkommen!
Das Institut für die Erforschung Pankreatischer Inselzellen erforscht die Krankheitsursachen des Diabetes mellitus Typ 1, Typ 2 sowie des Schwangerschaftsdiabetes. Dabei sorgen zerstörte oder in ihrer Funktion eingeschränkte Betazellen für einen erhöhten Blutzuckerspiegel. Die Wissenschaftler des IPI/PLID arbeiten daran die Mechanismen zu entschlüsseln, die die Zerstörung und/oder Funktionseinschränkung der Betazellen bedingen und versuchen darüber hinaus neue Ansätze zu entwickeln um die geschädigten bzw. zerstörten Betazellen zu ersetzen.
News
alle News
We protect your privacy by not directly incorporating third-party content unless you have expressly consented to its display through our cookie layer. In this special case it concerns the embedment of twitter including their data policy. If you agree now, this will indicate that content of twitter and the transfer of data to twitter beginns. The legal basis for processing the data is if the user has given his consent according to Art. 6 Para. 1 S. 1 lit. a DSGVO.
Aktuelle Publikationen des Instituts
Hier finden Sie die 10 aktuellsten Publikation unseres Instituts. Sollten Sie nach älteren Veröffentlichungen suchen, folgen Sie bitte dem nachstehenden Link zu unseren Publikationen.
- Stefan et al. Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry. Front Med (Lausanne). 2022 May 11;9:875430. doi: 10.3389/fmed.2022.875430. eCollection 2022.
- Rohner et al. Treating Insulin Resistance with Intermittent Personalized Nutrition to Sustain Metabolic Health and Functioning Immune System for Risk Reduction of Viral Diseases Especially COVID-19 and Long-COVID. Horm Metab Res. 2022 May 30. doi: 10.1055/a-1864-8234.
- Ludwig et al. Quality of life and metabolic outcomes after total pancreatectomy and simultaneous islet autotransplantation. Commun Med (Lond). 2022 Mar 3;2:24. doi: 10.1038/s43856-022-00087-7. eCollection 2022.
- Kübler et al. Local problems need global solutions: The metabolic needs of regenerating organisms. Wound Repair Regen. 2022 May 21. doi: 10.1111/wrr.13029.
- Bornstein et al.Progress in islet transplantation is more important than ever. Nat Rev Endocrinol. 2022 May 16:1-2. doi: 10.1038/s41574-022-00689-0.
- Bretschneider et al. Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study. Nutrients. 2022 Apr 26;14(9):1810. doi: 10.3390/nu14091810.
- Zielmann et al. Autoantibodies against ATP4A are a feature of the abundant autoimmunity that develops in first-degree relatives of patients with type 1 diabetes. Pediatr Diabetes. 2022 May 13. doi: 10.1111/pedi.13361.
- Rehn et al. PTBP1 promotes hematopoietic stem cell maintenance and red blood cell development by ensuring sufficient availability of ribosomal constituents. Cell Rep. 2022 May 10;39(6):110793. doi: 10.1016/j.celrep.2022.110793.
- Nakamura et al. Long-term feeder-free culture of human pancreatic progenitors on fibronectin or matrix-free polymer potentiates β cell differentiation. Stem Cell Reports. 2022 May 10;17(5):1215-1228. doi: 10.1016/j.stemcr.2022.03.013. Epub 2022 Apr 21.
- Belavgeni et al. Schwann cell necroptosis in diabetic neuropathy. Proc Natl Acad Sci U S A. 2022 Apr 26;119(17):e2204049119. doi: 10.1073/pnas.2204049119. Epub 2022 Apr 21.
